Literature DB >> 24007744

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.

Maria C Carrillo1, Robert A Dean, François Nicolas, David S Miller, Robert Berman, Zaven Khachaturian, Lisa J Bain, Rachel Schindler, David Knopman.   

Abstract

In 2011, the National Institute on Aging and the Alzheimer's Association (NIA-AA) proposed revising the criteria for diagnosing Alzheimer's disease (AD), which had been established more than 25 years earlier by the National Institute on Neurologic and Communicative Disorders and Stroke (NINCDS) and the Alzheimer's Disease and Related Disorders Association (ADRDA), now called the Alzheimer's Association. The NIA-AA initiative also built upon research criteria for AD proposed by the International Working Group (IWG) in 2007 and updated in 2010. These efforts to revise the criteria reflect the need to improve diagnostic accuracy, facilitate clinical trials, and establish a common set of criteria that are universally accepted across domains of clinical practice, research, and drug development. To ensure that the proposed NIA-AA criteria remain as current as possible, the Alzheimer's Association Research Roundtable convened a meeting in Washington, DC, on October 1 and 2, 2012, bringing together international stakeholders from industry, academia, and regulatory agencies to identify areas of agreement and research gaps respective of NIA-AA criteria and IWG recommendations.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarkers; Dementia; Diagnostic criteria

Mesh:

Year:  2013        PMID: 24007744     DOI: 10.1016/j.jalz.2013.05.1762

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  15 in total

1.  In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.

Authors:  Wanda M Snow; Ryan Dale; Zoe O'Brien-Moran; Richard Buist; Danial Peirson; Melanie Martin; Benedict C Albensi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease.

Authors:  Xiaonan Liu; Kewei Chen; Teresa Wu; David Weidman; Fleming Lure; Jing Li
Journal:  Transl Res       Date:  2018-01-10       Impact factor: 7.012

3.  Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease.

Authors:  Lisa Mosconi; Pauline F McHugh
Journal:  Curr Nutr Rep       Date:  2015-06-01

Review 4.  Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.

Authors:  Ricardo Apátiga-Pérez; Luis O Soto-Rojas; B Berenice Campa-Córdoba; Nabil Itzi Luna-Viramontes; Elvis Cuevas; Ignacio Villanueva-Fierro; Miguel Angel Ontiveros-Torres; Marely Bravo-Muñoz; Paola Flores-Rodríguez; Linda Garcés-Ramirez; Fidel de la Cruz; José Francisco Montiel-Sosa; Mar Pacheco-Herrero; José Luna-Muñoz
Journal:  Metab Brain Dis       Date:  2021-08-18       Impact factor: 3.584

5.  IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Michael Y F Yuen; Xiaopu Zhou; Deejay S Y Mak; Ivy C W Chan; Tom H Cheung; Baorong Zhang; Wing-Yu Fu; Foo Y Liew; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

6.  Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.

Authors:  Anna Pensalfini; Seonil Kim; Shivakumar Subbanna; Cynthia Bleiwas; Chris N Goulbourne; Philip H Stavrides; Ying Jiang; Ju-Hyun Lee; Sandipkumar Darji; Monika Pawlik; Chunfeng Huo; James Peddy; Martin J Berg; John F Smiley; Balapal S Basavarajappa; Ralph A Nixon
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

Review 7.  Genetic markers in biological fluids for aging-related major neurocognitive disorder.

Authors:  S A Castro-Chavira; T Fernandez; H Nicolini; S Diaz-Cintra; R A Prado-Alcala
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

8.  Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.

Authors:  Marius Chiasseu; Luis Alarcon-Martinez; Nicolas Belforte; Heberto Quintero; Florence Dotigny; Laurie Destroismaisons; Christine Vande Velde; Fany Panayi; Caroline Louis; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2017-08-03       Impact factor: 14.195

9.  Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.

Authors:  Asha Singanamalli; Haibo Wang; Anant Madabhushi
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

10.  Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production.

Authors:  Lingli Yan; Yuanyuan Deng; Jianmei Gao; Yuangui Liu; Fei Li; Jingshan Shi; Qihai Gong
Journal:  Front Pharmacol       Date:  2017-03-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.